Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Completed1
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

unknown125%
completed125%
not_yet_recruiting125%
withdrawn125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

Effects of a Resistance Physical Exercise Program in Multiple Myeloma Patients

NCT07253103
withdrawnnot_applicable

Evaluation of Physical Exercise to Prevent Functional Deterioration During Hospitalization (EFFAPRO)

NCT05281250
completednot_applicable

Kuopio Fall Prevention Study.

NCT02665169
unknownnot_applicable

Physical Exercise, Endothelial Function and Progenitor Endothelial Cells in Systemic Lupus Erythematosus Patients

NCT01712529

Clinical Trials (4)

Showing 4 of 4 trials
NCT07253103Not Applicable

Effects of a Resistance Physical Exercise Program in Multiple Myeloma Patients

Not Yet Recruiting
NCT05281250Not Applicable

Evaluation of Physical Exercise to Prevent Functional Deterioration During Hospitalization (EFFAPRO)

Withdrawn
NCT02665169Not Applicable

Kuopio Fall Prevention Study.

Completed
NCT01712529Not Applicable

Physical Exercise, Endothelial Function and Progenitor Endothelial Cells in Systemic Lupus Erythematosus Patients

Unknown

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4